←
Carrie Thompson, MD2,243 posts
Carrie Thompson, MD avatar

Carrie Thompson, MD

@CaThompsonMD

@MayoMN_IMRES PD, Hematology/Lymphoma @MayoClinic, passionate about #mentorship, cancer survivorship, & my family. Tweets are my own.

◷ Joined December 2011▧ 218 Photos and videos
Carrie Thompson, MD avatar
Carrie Thompson, MD@CaThompsonMD·20 May 2020

I am incredibly honored and excited to serve @MayoMN_IMRES! @AmyOxentenkoMD (my former #CMR!) has been an amazing #PD and I hope to carry on her advocacy, innovation, & empathy. Residents, thank you for the warm welcome! And to my @MayoHemeOnc fellows, I will miss you dearly.

Congratulations to our newly selected Mayo Clinic Internal Medicine Residency Program Director Dr. Carrie Thompson! Dr. Thompson is a consultant in Hematology, and she will transition from her role as a program director for Mayo RST Heme/Onc fellowship. @CaThompsonMD

Post attachment
Vincent Rajkumar avatar
⟳ Carrie Thompson, MD retweeted
Vincent Rajkumar@VincentRK·1 Oct 2025

Just out in the New England Journal of Medicine! Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM nejm.org/doi/full/10.1056/NE… 5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. Bookmark! How to test and manage patients. Who needs bone marrow exams and scans. It’s all in here! MGUS is important not just because it’s a precursor to multiple myeloma. It causes a lot of other problems. Learn all about MGUS, and the various terms you hear MGCS, MGRS etc. in this Review @myelomaMD and I have tried to keep every sentence in this Review simple and easy to follow. #MGUSVR

Post attachment
Jonathan Friedberg avatar
⟳ Carrie Thompson, MD retweeted
Jonathan Friedberg@DrJFriedberg·26 Sep 2025

PROs vs clinician-reported adverse events in the POLARIX study: we are insufficiently capturing patient experience with conventional toxicity assessments. Great collaboration with Dr. Carrie Thompson @MayoClinic @WilmotCancer ashpublications.org/blood/ar…

JAMA Oncology avatar
⟳ Carrie Thompson, MD retweeted
JAMA Oncology@JAMAOnc·11 Sep 2025

Patient-reported outcomes, such as higher health status and lower symptom burden, are independently associated with improved overall survival in cancer patients. ja.ma/4n9p0TG @RSTHuang

Post attachment
Mayo Clinic Internal Medicine Residency Rochester avatar
⟳ Carrie Thompson, MD retweeted
Mayo Clinic Internal Medicine Residency Rochester@MayoMN_IMRES·4 Jun 2025

#WIM Last night, our Women In Medicine Group held an amazing event with round table discussions for residents and women leaders in Medicine! We were fortunate enough to have our PD, APDs, Rotation Director, and ACG President/ Vice Dean of Practice for Mayo Clinic in attendance!

Post attachmentPost attachmentPost attachment
Gianrico Farrugia avatar
⟳ Carrie Thompson, MD retweeted
Gianrico Farrugia@GFarrugiaMD·21 Mar 2025

Congratulations to the next generation of physicians who matched to residency programs today at Mayo Clinic and across the nation. I hope you’ll continue to embrace the opportunities ahead as you shape the future of patient care. #Match2025

Post attachmentPost attachmentPost attachmentPost attachment
Carrie Thompson, MD avatar
Carrie Thompson, MD@CaThompsonMD·9 Jan 2025

😀😍😎🥺🤗 Our emoji PRO paper is published! Will this change the way that we collect patient reported outcomes in hematology and oncology? 🤔 @MayoHemeOnc @MayoCancerCare

Please select the one emoji that best represents your feeling towards our research paper developing emoji scales for assessing #patientreportedoutcomes: 😩 ☹️ 😐 🙂 😄 @CaThompsonMD ascopubs.org/doi/abs/10.1200…

Amylou Dueck, PhD avatar
⟳ Carrie Thompson, MD retweeted
Amylou Dueck, PhD@BiostatGirl·8 Jan 2025

Please select the one emoji that best represents your feeling towards our research paper developing emoji scales for assessing #patientreportedoutcomes: 😩 ☹️ 😐 🙂 😄 @CaThompsonMD ascopubs.org/doi/abs/10.1200…